NanoLogix Inc (NNLX)

[capitalismforever]

For those trying to ascertain margins for Nanologix, in 2011 they supplied the answer.

Our current monthly operations costs are approximately $60,000.00. That amount does not include the costs of FDA applications, NanoLogix-funded studies, other tests of our products by third parties, and new patent applications. At this point, NanoLogix is funded almost entirely by private placement stock sales, with approximately 25 qualified investors providing funding in exchange for common stock restricted from market sale for one year from date of issuance. To our knowledge, the majority of the private placement shares are retained by the investors after the one-year maturation. The company does not sell shares on the open market. That cannot be done without a new public stock offering and we foresee no justification for that to occur.

Source: http://nanologix.com/news/2011_company_update.html

That means if the company produces $720,000 in annual revenue (which they don't), net income equals $0. That also means the company would need to produce at least $150,000 in excess of that amount to justify a $0.06 per share price.

When the company released this information, the financial statements indicated that the company was actually spending over $80,000 per month in expenses, so the amounts not included in the CEO's letter amounted to an addition $20,000 per month. That means the company would need to produce $1.11 million per year in revenue to justify a $0.06 per share price.

After 10 years, they're nowhere close. But hey, at least the CEO's bills are being paid...right? ;)

Maybe the CEO should go on Shark Tank. lol.